These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 754999)

  • 21. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 22. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nifedipine and essential arterial hypertension refractory to hypotensive therapy: results of a preliminary double-blind study].
    Del Guercio R; Gentile S
    Clin Ter; 1981 Jan; 96(1):45-54. PubMed ID: 7016410
    [No Abstract]   [Full Text] [Related]  

  • 24. [Spironolactone combined with chlorthalidone in the treatment of essential arterial hypertension].
    Gragnoli G; Puccetti F; Tanganelli I; Favilli R; Nami R
    Minerva Med; 1975 Apr; 66(30):1412-6. PubMed ID: 1143685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorthalidone - a renaissance in use?
    Sica DA
    Expert Opin Pharmacother; 2009 Sep; 10(13):2037-9. PubMed ID: 19663607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily combination therapy for hypertension.
    Asbury MJ; Wells FO; Barker NP
    Practitioner; 1980 Dec; 224(1350):1306-9. PubMed ID: 7012818
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of labetalol as a single treatment and labetalol combined with chlorthalidone in the treatment of severe arterial hypertension].
    Franco F; Colombo G; Salvioli G; Planca E
    Boll Chim Farm; 1988; 127(11-12):71S. PubMed ID: 3254253
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of atenolol and an atenolol-chlorthalidone combination on blood pressure values in hypertensive patients].
    Novo S; Immordino R; Giannola A; Gullotti D; Strano A
    Clin Ter; 1985 Mar; 112(6):493-502. PubMed ID: 4017474
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic prospectives in the field of hypertension].
    Delsignore R; Baroni MC; Mineo F; Crotti G; Butturini U
    Clin Ter; 1985 Aug; 114(4):301-6. PubMed ID: 3902338
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinico-therapeutic evaluation of the hypertensive patient by the isometric exertion test].
    Maiorano G; Contursi V; Petrelli G; Loiacono N; Bovenzi F; Ricapito M
    Minerva Cardioangiol; 1986 Mar; 34(3):107-17. PubMed ID: 3714062
    [No Abstract]   [Full Text] [Related]  

  • 34. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term experiences with an antihypertensive combination].
    Hilgert A; Horch G
    Med Welt; 1982 Jul; 33(29-30):1067-70. PubMed ID: 6750310
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of hypertension with a new combination of beta blocking agents and saluretics].
    Deibert K
    Med Welt; 1980 Sep; 31(36):1288-90. PubMed ID: 7442528
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
    Budriesi N; Adalio G; Zamboni A; Turina MC
    G Clin Med; 1986 Apr; 67(2):109-13. PubMed ID: 3792715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.